Evidence map›Paper›PMID 41821407›Full record

ArticleActa anaesthesiologica Scandinavica2026

Neuromuscular Block and Video Laryngoscope to Facilitate Intubation-A Survey of Current Practice in Denmark and Sweden.

Åse Lodenius, Louise Holland-Bill, Emil Ørskov Ipsen, Maria Cronhjort, Arash Afshari, Matias Vested, Andreas Creutzburg, Lars Hyldborg Lundstrøm, Helene Korvenius Nedergaard, Anders Kehlet Nørskov and 1 more

Abstract read
In one paragraph

Article in Acta anaesthesiologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Åse LodeniusDepartment of Anaesthesia and Intensive Care, Danderyd Hospital, Stockholm, Sweden.
Louise Holland-BillCollaboration for Evidence-Based Practice and Research in Anaesthesia (CEPRA), Copenhagen, Denmark.
Emil Ørskov IpsenDepartment of Anaesthesiology, Nordsjællands Hospital, Hillerød, Denmark.
Maria CronhjortDepartment of Anaesthesia and Intensive Care, Danderyd Hospital, Stockholm, Sweden.ORCID 0000-0002-0444-8553
Arash AfshariDepartment of Anaesthesiology, Juliane Marie Centre, Copenhagen, Denmark.
Matias VestedDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Andreas CreutzburgDepartment of Anaesthesiology, Nordsjællands Hospital, Hillerød, Denmark.
Lars Hyldborg LundstrømCollaboration for Evidence-Based Practice and Research in Anaesthesia (CEPRA), Copenhagen, Denmark.ORCID 0000-0002-2179-1433
Helene Korvenius NedergaardCollaboration for Evidence-Based Practice and Research in Anaesthesia (CEPRA), Copenhagen, Denmark.ORCID 0000-0002-5988-4563
Anders Kehlet NørskovCollaboration for Evidence-Based Practice and Research in Anaesthesia (CEPRA), Copenhagen, Denmark.ORCID 0000-0002-6908-7832
ROCVIDEO Survey Collaborator Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuromuscular blocking agents (NMBA) provide optimal conditions for tracheal intubation. A high dose of opioid can be used as an alternative but may give suboptimal conditions for intubation. The use of a video laryngoscope for intubation might eliminate this potential difference.

methodsA survey examining clinical practice regarding tracheal intubation with and without NMBA and use of video laryngoscopes was conducted in Sweden and Denmark.

results1771 out of 3181 (56%) of invited anaesthetists responded. Overall, 1365/1771 (77%) preferred using NMBAs for non-acute tracheal intubation with a considerably higher NMBA preference in Sweden 1011/1073 (94%) than in Denmark 354/700 (51%). A high proportion of Danish anaesthetists 327/700 (47%) compared to 40/1071 (4%) of Swedish anaesthetists reported primarily using opioids without NMBA. Remifentanil was the preferred opioid (1158/1361 (85%)) for intubation without NMBA. The reasons for using NMBA were improved intubating conditions (948/1771 (54%)), departmental tradition (285/1771 (16%)), adherence to local guidelines (264/1771 (15%)), and adherence to national/international guidelines (143/1771 (8%)). Video laryngoscopes were present in every operating theatre for 349/700 (50%) of Danish anaesthetists and 131/1071 (12%) of Swedish anaesthetists. Video laryngoscopes were easily accessible outside the operating room for 350/700 (50%) of Danish anaesthetists and 940/1071 (88%) of Swedish anaesthetists.

conclusionsNMBA use remains the standard for non-acute tracheal intubation. However, a substantial number of anaesthetists regularly employ a NMBA-free approach facilitated by high-potency opioids and video laryngoscopy, particularly in Denmark. These findings emphasise the need for further research and subsequently updated evidence-based guidance to support safe and effective intubation practices. EDITORIAL COMMENT: This study, reporting a survey of anesthesia practitioners in Sweden and Denmark assessed preferences concerning how the respondents would manage a series of case scenarios concerning anesthetic drug choices for facilitation of intubation and employment of video laryngoscopy. Quite a bit of variation for preferences is presented by the responses concerning neuromuscular blockade or not to facilitate intubation.

Indexed as

Intubation, IntratrachealLaryngoscopesLaryngoscopyNeuromuscular BlockadePractice Patterns, Physicians'Analgesics, OpioidDenmarkHumansNeuromuscular Blocking AgentsSurveys and QuestionnairesSwedenAnalgesics, OpioidNeuromuscular Blocking Agentsanaesthesiageneral intubationintratracheal laryngoscopyneuromuscular blocking agentsremifentanil

Identifiers

PMID41821407
PMCPMC12983051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.